Skip to content

In the Know: Key Abstracts from the American Society of Hematology 2021 Annual Meeting in Acute Lymphoblastic Leukemia
***Poster 3 Pre-assessment***

Before you view the poster session, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit. 

Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit.
1.What are your credentials? (Required.)
2.What is your specialty?
3.How confident are you in the management of patients with ALL in your practice?
Very confident
Confident
Neutral
Little confidence
No confidence
4.OA is a 13-year-old male diagnosed with B-cell ALL. 
  • His white blood cell count at diagnosis was 40 x109/L and he did not have CNS involvement.
  • He received induction on UKALL 2003 and his day 8 bone marrow biopsy showed a rapid early response with 5% blasts.
  • At the end of induction his bone marrow biopsy showed MRD < 0.01% and he proceeded with reduced-intensity therapy with 1 delayed intensification followed by maintenance therapy for 2.5 years.
  • At a follow-up appointment 5 years after his diagnosis his parents would like to understand the likelihood of long-term overall survival.
Which of the following is the most appropriate response?(Required.)
5.After 10 years of follow-up in the UKALL 2003 trial, augmentation of treatment intensity in children and adolescent young adult (AYA) with acute lymphoblastic leukemia (ALL) and minimal residual disease (MRD) > 0.01% at the end of induction was associated with which of the following outcomes?(Required.)
6.Dosing pegaspargase at 500 U/m2 in patients with elevated risk for hepatoxicity on the GMALL Trial 8/2013 was associated with which of the following outcomes?(Required.)
7.Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity) 
Privacy & Cookie Notice